Study found that pregnant mothers with COVID-19 face a significantly higher risk of severe maternal morbidity (SMM), including adult respiratory distress syndrome and acute renal failure, emphasizing the urgent need for their early diagnosis and treatment.
Teva’s new royalty deal; Selecta merges with Cartesian; Vir’s hepatitis data
Teva inks deal with Royalty Pharma for schizophrenia drug: The Israeli drugmaker said Monday that it will receive $100 million to complete an ongoing Phase